Cognex (NASDAQ:CGNX) Releases Earnings Results, Beats Expectations By $0.03 EPS

Cognex (NASDAQ:CGNX) posted its quarterly earnings results on Wednesday. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.03, FiscalAI reports. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The company had revenue of $291.26 million for the quarter, compared to analysts’ expectations of $292.10 million. During the same quarter in the previous year, the firm posted $0.25 EPS. Cognex’s revenue was up 16.9% on a year-over-year basis. Cognex updated its FY 2026 guidance to 1.640-1.680 EPS and its Q3 2026 guidance to 0.500-0.540 EPS.

Cognex Price Performance

NASDAQ:CGNX opened at $70.71 on Thursday. Cognex has a 1 year low of $34.60 and a 1 year high of $72.88. The stock’s fifty day moving average price is $64.96 and its two-hundred day moving average price is $56.90. The company has a market cap of $11.77 billion, a P/E ratio of 84.18 and a beta of 1.49.

Cognex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Thursday, August 20th will be given a dividend of $0.085 per share. The ex-dividend date is Thursday, August 20th. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. Cognex’s dividend payout ratio is currently 40.48%.

Insider Activity

In related news, insider Mark Fennell sold 64,873 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the sale, the insider owned 11,263 shares of the company’s stock, valued at approximately $755,184.15. This represents a 85.21% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Laura Ann Macdonald sold 98,122 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $66.80, for a total value of $6,554,549.60. Following the completion of the transaction, the vice president owned 5,258 shares of the company’s stock, valued at approximately $351,234.40. This represents a 94.91% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 224,847 shares of company stock worth $14,975,098. 1.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Cognex

Several hedge funds and other institutional investors have recently modified their holdings of CGNX. Quadrant Capital Group LLC increased its holdings in Cognex by 1.0% in the 4th quarter. Quadrant Capital Group LLC now owns 22,907 shares of the scientific and technical instruments company’s stock valued at $824,000 after acquiring an additional 234 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Cognex by 12.9% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,132 shares of the scientific and technical instruments company’s stock worth $68,000 after purchasing an additional 243 shares in the last quarter. Public Employees Retirement System of Ohio boosted its holdings in shares of Cognex by 0.5% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 54,349 shares of the scientific and technical instruments company’s stock valued at $2,462,000 after purchasing an additional 292 shares during the last quarter. CIBC Private Wealth Group LLC grew its position in shares of Cognex by 74.8% during the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after purchasing an additional 327 shares in the last quarter. Finally, Snowden Capital Advisors LLC grew its position in shares of Cognex by 2.0% during the second quarter. Snowden Capital Advisors LLC now owns 17,326 shares of the scientific and technical instruments company’s stock valued at $550,000 after purchasing an additional 338 shares in the last quarter. 88.12% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CGNX has been the subject of a number of recent research reports. Truist Financial raised their target price on Cognex from $61.00 to $71.00 and gave the stock a “hold” rating in a research report on Thursday, July 2nd. Robert W. Baird set a $72.00 price target on Cognex in a research note on Friday, May 8th. Needham & Company LLC lifted their price objective on Cognex from $67.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, May 8th. Sanford C. Bernstein restated an “outperform” rating and issued a $75.00 price objective on shares of Cognex in a research note on Thursday, May 7th. Finally, Stephens upped their price objective on shares of Cognex from $65.00 to $75.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $72.31.

Cognex News Roundup

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Second-quarter adjusted EPS was $0.45, beating the $0.42 consensus estimate and rising from $0.25 a year earlier. Revenue reached a record $291 million, up 16.9% year over year, while net income increased 78% to $72.8 million. Cognex Corporation Tops Q2 Earnings Estimates
• Positive Sentiment: Management issued guidance well above analyst expectations. Third-quarter EPS is projected at $0.50–$0.54 versus the $0.37 consensus, with revenue of $300–$320 million versus $279.2 million expected. Full-year EPS guidance of $1.64–$1.68 also exceeds the $1.48 consensus, and revenue is forecast at $1.13–$1.15 billion. Cognex Reports Second Quarter 2026 Results
• Positive Sentiment: Cognex declared a quarterly cash dividend of $0.085 per share, payable September 3 to shareholders of record August 20, signaling continued confidence in cash generation.
• Neutral Sentiment: Growth was described as broad-based across most major end markets, supporting the company’s recovery and expansion outlook. However, CGNX trades at a high valuation, with a reported price-to-earnings ratio above 84, leaving the shares sensitive to any slowdown or guidance disappointment.
• Negative Sentiment: Quiver Quantitative data shows 16 insider sales and no insider purchases over the past six months. Several executives sold shares, which may raise caution about valuation even though insider transactions do not necessarily indicate deteriorating business conditions. Cognex Q2 Revenue Hits Record $291 Million

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.